A detailed history of Polar Capital Holdings PLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 35,585 shares of LAB stock, worth $56,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,585
Previous 56,585 37.11%
Holding current value
$56,936
Previous $100,000 32.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.42 - $2.35 $29,820 - $49,350
-21,000 Reduced 37.11%
35,585 $68,000
Q4 2023

Feb 14, 2024

SELL
$1.59 - $2.73 $69,029 - $118,522
-43,415 Reduced 43.42%
56,585 $125,000
Q1 2023

May 15, 2023

BUY
$1.3 - $2.24 $130,000 - $224,000
100,000 New
100,000 $195,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $126M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.